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CASE STUDY
Introduction
The term “myalgic encephalomyelitis” (ME), was fi rst included 
by the World Health Organization (WHO) in its international 
classification of diseases in 1969. Other name labels, such 
as post-viral fatigue syndrome, idiopathic environmental 
intolerance syndrome (IEI), multiple chemical sensitivity 
syndrome and chronic fatigue syndrome (CFS), have been 
historically used to refer to ME, possibly because of inadequate 
knowledge of the disease aetiopathogenesis. Furthermore, the 
disease has been described as a “twentieth century disease” or 
“contested illness”, leading to confl ict and mistrust between 
sufferers and healthcare professionals.1 In 2007, the WHO 
acknowledged ME as a disease of the nervous system, under 
the code G93.3. Recent research and clinical experience with 
these patients has resulted in the identifi cation of unique and 
distinctive characteristic patterns of symptom clusters of ME, as 
set out in the international consensus criteria, published by an 
international group of clinicians, researchers, a teaching faculty 
and patient advocates in 2011.2 This document provides a clear 
understanding of the complexity of this disease. It also off ers 
clarity on diagnosis and clinical treatment criteria, based on 
current knowledge.  
It is now scientifically proven that ME is a multifaceted 
organic disease with a sudden onset after a viral infection in a 
previously fi t and healthy individual, and involves signifi cant 
dysregulation of the central nervous, cardiovascular and 
immune systems, cellular metabolism and ion transport 
mechanisms.2,3 Characteristically, it presents with incapacitating 
fatigue not improved by rest, and multiple other neurological, 
cognitive, immune, metabolic, cardiovascular, respiratory, 
gastrointestinal and/or genitourinary symptoms.2 The incidence 
of ME is estimated to be 0.5 % in the Western world,4 and it 
aff ects females twice as commonly as males, with a peak in the 
most productive part of the adult life, therefore representing 
a signifi cant burden to both the diseased patient and society. 
When a ME patient is exposed to intervening stress, such 
as a surgical intervention, the effect on the recurrence 
and aggravation of symptoms can be unpredictable, and 
postoperative recovery may be prolonged. We present the 
anaesthetic management of a ME patient who underwent 
breast cancer surgery. 
Case report
A 61-year-old woman, diagnosed with ME in the early 1990s, 
maintained normal essential physiology since, except for 
occasional intermittent episodes of significantly reduced 
energy levels. Her medical history was otherwise insignifi cant. 
Calcium supplements were her only regular medication. 
Previous general anaesthesia for a minor gynaecological 
procedure 20 years previously resulted in a severe ME relapse, 
with substantial energy loss, impaired vision, tinnitus, balance 
impairment and headaches which lasted for two years 
thereafter.  
On this occasion, she was diagnosed with high-grade 
ductal carcinoma in situ, under the auspices of the breast 
screening programme, and scheduled for a wide local excision 
with sentinel lymph node biopsy. She was referred to the 
anaesthesia assessment clinic for assessment and planning of 
imminent anaesthesia management. The preoperative physical 
examination, laboratory tests and investigations were all within 
normal limits. 
From the outset, the patient refused the option of general 
anaesthesia and/or sedation for the scheduled procedure. 
Therefore, we discussed the option of a paravertebral blockade 
(PVB) and/or deep tissue infi ltration with a local anaesthetic 
with her. Regional technique failure rates and complications, 
as well as the possibility of conversion to general anaesthesia, 
were thoroughly discussed with the patient.  
On the day of surgery, after intravenous cannulation and 
monitoring, a right-sided paravertebral block was performed at 
T3 level in a left lateral position, using a landmark technique. 
After skin infi ltration with lignocaine 1% of an area 2.5 cm 
lateral to the spinous process of T3 vertebra, an 18-G Tuohy 
needle was inserted perpendicular to all planes until the 
transverse process of T4 vertebra was met at a depth of 3.7 cm. 
The needle was then walked off  the upper border of the T4 
transverse process, and advanced a further 0.3 cm until a subtle 
loss of resistance to normal saline 0.9% was felt. A test dose of 
bupivacaine 0.375% 3 ml was injected, after which a catheter 
was inserted 5 cm in the paravertebral space. Further boluses 
of bupivacaine 0.375% were injected in 5 ml increments, up to 
Paravertebral block as a sole technique for the anaesthetic management of a 
patient with myalgic encephalomyelitis undergoing breast cancer surgery
Kinsley Enohumah, S. Raza Mehdi, Alan J. McShane and Crina L. Burlacu*
Department of Anaesthesia, Intensive Care and Pain Medicine, St Vincent’s University Hospital, Dublin, Ireland
*Corresponding author, e-mail: c.burlacu@st-vincents.ie
Myalgic encephalomyelitis (ME) is a multifaceted organic disease which, owing to its non-specific multiple symptoms that 
include incapacitating fatigue, deeply affects the quality of life of diseased patients. It carries a perceived risk of an adverse 
reaction to drugs, including anaesthetics. However, there is very little information in the medical literature on the anaesthetic 
management and outcomes of patients with this condition. According to current scientific literature, there is no causal 
relationship between ME relapse and anaesthesia, surgery or both. We present the anaesthetic management of a ME patient 
who underwent breast cancer surgery. 





























Paravertebral block as a sole technique for the anaesthetic management of a patient with myalgic encephalomyelitis 165
a total of 20 ml. A right-sided sensory blockade was identifi ed 
from T1-T8 at both the midclavicular and midaxillary lines, after 
which surgery proceeded.
Intraoperatively, the patient remained haemodynamically 
stable and the surgery advanced uneventfully. She received 
further deep tissue infi ltration with lignocaine 1% 20 ml for 
some minor discomfort in the axillary area. Since the patient 
refused benzodiazepines, nonsteroidal anti-inflammatory 
drugs and opioid analgesics, an increased dose of paracetamol 
2 g was administered intravenously. Although unconventional, 
such a loading dose has been suggested to improve immediate 
postoperative analgesia without increased toxicity in healthy 
adults. The paravertebral catheter was removed at the end of 
surgery as per our institutional protocol. 
Postoperatively, the patient was comfortable, and one more 
oral dose of paracetamol 1 g was required overnight for minor 
pain. She recovered well and was discharged home the next 
day without any complications. Follow-up at two weeks after 
discharge showed that she had recovered well, without ME 
relapse.
Discussion
There is little published medical literature on the anaesthetic 
management and outcome of ME patients. Yet, anecdotal 
available evidence and information on a patient advocacy 
website5 suggests that ME patients may experience episodes 
of acute exacerbation of the disease after anaesthesia, which 
may be long term or even permanent. Alleged postoperative 
symptoms may include intense fatigue with an inability to 
perform daily activities for several years after surgery. Such 
a relapse was experienced by our patient after a minor 
gynaecological procedure under general anaesthesia which 
had been performed 20 years prior to the current surgical 
intervention. Because of such patient reports, and historical 
mistrust between sufferers and healthcare professionals, 
it is not surprising that patients present for surgery with 
misconceptions, and sometimes a checklist of medications 
and actions which are assumed to be accepted practice in the 
anaesthetic management of ME patients.5   
A few other case reports describe anaesthesia in ME patients. 
Meenakshi and Kumar reported the anaesthetic management 
of two ME female patients who underwent gynaecological 
procedures under spinal, followed by general anaesthesia, for 
incomplete sensory blockade.6 Both patients experienced an 
uneventful recovery and were discharged home without any 
further complications. In another case report, a patient with 
“sick house” or “sick building” syndrome (a ME-like syndrome, 
characterised by non-specific complaints associated with 
indoor environmental chemical pollution), developed non-
anaphylactoid bronchospasm on two occasions after propofol, 
and sudden intermittent severe headaches after surgery.7 On a 
third and fourth occasion, propofol was avoided, and no further 
bronchospasm occurred.
However, the best available scientifi c evidence for possible 
interaction between anaesthesia and ME derives from a 
retrospective observational study and literature review by 
Fisher and Rose, published in the British Journal of Anaesthesia 
in 2008.8 Of twenty-seven patients with CFS and IEI, referred 
to an anaesthetic clinic over a 20-year period, 23 had reported 
a history of problems relating to previous local anaesthesia, 
general anaesthesia or both. The historical anaesthetic records 
of 11 such patients demonstrated minor complications 
during the immediate perioperative period, such as intra- and 
postoperative hypotension responding to intravenous fl uids, 
hypertension, hypoglycaemia and slightly delayed awakening. 
Several patients complained of delayed symptoms, such as 
panic attacks, uncontrollable shaking, protracted nausea, 
muscular pain, tiredness and weakness; all self-limiting and not 
requiring further medical intervention. One patient reported 
untoward non-specific effects after both an epidural and 
general anaesthesia, whereas some patients reacted to local 
anaesthetics with vasovagal symptoms, swelling, hallucinations 
and fatigue. The authors proceeded with skin testing for 
general anaesthetic drugs, local anaesthetics or both. The 
results of these were non-specifi c, i.e. vasovagal reactions, a 
skin rash on the opposite arm, and an emotional breakdown 
in one patient, and bore no scientifi cally sound relationship to 
the tested anaesthetic drugs. Finally, the authors followed-up 
these patients through subsequent anaesthetics, where both 
local and general anaesthetics were used. Only one patient of 
the initial 27 experienced complications including narcolepsy, 
neurocognitive impairment, neuromotor disturbances and 
seizures. None of them required further medical referral. 
Further to a subsequent major surgical intervention, the same 
patient experienced nausea only. At the same time, Fisher 
and Rose8 also performed a comprehensive literature review 
of all published data over a 57-year period (1950-2007). They 
concluded that there was insufficient evidence to support 
a causal relationship between the reported non-specific 
responses and anaesthesia, surgery or a combination of both. 
There was no evidence that the anaesthetic risk was higher 
when a particular anaesthetic technique and/or drug was 
preferred over another, nor that ME patients were at higher 
anaesthetic risk than non-diseased patients. Therefore, the 
anaesthetic management of such patients should not be 
modifi ed. However, the anaesthetist should carefully consider 
the patient’s history and demands, regardless of whether 
or not they sound unreasonable, and, in general, create an 
atmosphere of mutual trust, while administering a “safe 
technique” by avoiding drugs to which the patient says that he 
or she has experienced an adverse reaction. 
As per Fisher and Rose’s sound observations and 
recommendations, we carefully assessed the extent of the 
background disease, adverse events history, and results of 
the clinical examination and investigations in our patient. 
Unfortunately, we were not able to retrieve historical 
anaesthetic notes to further help us to plan the anaesthetic 
management. We discussed diff erent options with both the 
patient and surgeons, and weighted various risks and benefi ts. 
Given the patient’s strong preference for regional anaesthesia 
without sedation, we opted for a PVB only. Since its first 
description as a suitable alternative to general anaesthesia 
in women undergoing breast surgery,9 single-injection PVB 
alone, or combined with general anaesthesia, has been shown 
to provide better postoperative analgesia, less postoperative 
nausea and vomiting and better alertness scores, with little 
adverse effects, than other analgesic strategies for breast 
surgery.9,10 The risk of technique failure, incomplete analgesia 
and the need to convert to general anaesthesia were discussed 
in detail.
In conclusion, after carefully weighing the available evidence 
in connection with anaesthesia-related complications, and the 
risks and benefi ts of various anaesthetic techniques, as well 
as the patient’s demands, we were able to provide successful 
regional anaesthesia for breast cancer surgery, and avoid 
general anaesthesia and/or sedation in a patient with ME who 
experienced  severe disease relapse after a previous general 




























Southern African Journal of Anaesthesia and Analgesia 2014; 20(3):164–166166
Despite recent progress that has been made in the diagnosis 
and primary treatment of ME, it is likely that ME patients will 
continue to pose considerable challenges to anaesthetists 
owing to the unpredictability of its non-specifi c symptoms. 
The current evidence, albeit limited, suggests that there is no 
correlation between a particular anaesthesia drug or technique 
and recovery from anaesthesia. Yet, patients will continue 
to look for reassurance that their perioperative course will be 
uneventful, and without consequence to their quality of life. 
Therefore, we suggest that careful preoperative assessment, 
a sound doctor-patient relationship, and a selective approach 
to anaesthesia, specifi c to the patient’s condition and type of 
surgery, will ensure safe perioperative management of this 
group of patients.
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